FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q38610220> ?p ?o ?g. }

• Q38610220 description "2017 nî lūn-bûn" @default.
• Q38610220 description "2017年の論文" @default.
• Q38610220 description "2017年論文" @default.
• Q38610220 description "2017年論文" @default.
• Q38610220 description "2017年論文" @default.
• Q38610220 description "2017年論文" @default.
• Q38610220 description "2017年論文" @default.
• Q38610220 description "2017年论文" @default.
• Q38610220 description "2017年论文" @default.
• Q38610220 description "2017年论文" @default.
• Q38610220 description "2017年论文" @default.
• Q38610220 description "2017年论文" @default.
• Q38610220 description "2017年论文" @default.
• Q38610220 description "2017년 논문" @default.
• Q38610220 description "article científic" @default.
• Q38610220 description "article scientific" @default.
• Q38610220 description "article scientifique" @default.
• Q38610220 description "articol științific" @default.
• Q38610220 description "articolo scientifico" @default.
• Q38610220 description "artigo científico" @default.
• Q38610220 description "artigo científico" @default.
• Q38610220 description "artigo científico" @default.
• Q38610220 description "artikel ilmiah" @default.
• Q38610220 description "artikull shkencor" @default.
• Q38610220 description "artikulong pang-agham" @default.
• Q38610220 description "artykuł naukowy" @default.
• Q38610220 description "artículo científico" @default.
• Q38610220 description "artículu científicu espublizáu en 2017" @default.
• Q38610220 description "bilimsel makale" @default.
• Q38610220 description "bài báo khoa học" @default.
• Q38610220 description "naučni članak" @default.
• Q38610220 description "scienca artikolo" @default.
• Q38610220 description "scientific article published on 24 August 2017" @default.
• Q38610220 description "scientific article published on 24 August 2017" @default.
• Q38610220 description "scientific article published on 24 August 2017" @default.
• Q38610220 description "teaduslik artikkel" @default.
• Q38610220 description "tieteellinen artikkeli" @default.
• Q38610220 description "tudományos cikk" @default.
• Q38610220 description "vedecký článok" @default.
• Q38610220 description "vetenskaplig artikel" @default.
• Q38610220 description "videnskabelig artikel" @default.
• Q38610220 description "vitenskapelig artikkel" @default.
• Q38610220 description "vitskapeleg artikkel" @default.
• Q38610220 description "vědecký článek" @default.
• Q38610220 description "wetenschappelijk artikel" @default.
• Q38610220 description "wissenschaftlicher Artikel" @default.
• Q38610220 description "επιστημονικό άρθρο" @default.
• Q38610220 description "мақолаи илмӣ" @default.
• Q38610220 description "наукова стаття, опублікована в серпні 2017" @default.
• Q38610220 description "научна статия" @default.
• Q38610220 description "научная статья" @default.
• Q38610220 description "научни чланак" @default.
• Q38610220 description "научни чланак" @default.
• Q38610220 description "מאמר מדעי" @default.
• Q38610220 description "مقالة علمية نشرت في 24 أغسطس 2017" @default.
• Q38610220 description "বৈজ্ঞানিক নিবন্ধ" @default.
• Q38610220 description "บทความทางวิทยาศาสตร์" @default.
• Q38610220 description "სამეცნიერო სტატია" @default.
• Q38610220 name "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 name "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 name "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 type Item @default.
• Q38610220 label "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 label "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 label "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 prefLabel "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 prefLabel "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 prefLabel "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 P1433 Q38610220-4030C0FF-73AC-412A-AAD0-A19C7FB053C0 @default.
• Q38610220 P1476 Q38610220-2EDA95AC-1C5E-4215-BAD4-FD7FEF152EE2 @default.
• Q38610220 P2093 Q38610220-0747970F-7E0B-43A3-9EB9-F588DCF03CCF @default.
• Q38610220 P2093 Q38610220-20650D27-B0D2-405D-B6EE-7D4353373402 @default.
• Q38610220 P2093 Q38610220-310D5EC9-AF17-4DD8-8FF4-32208EC1840D @default.
• Q38610220 P2093 Q38610220-4B4EA107-49D1-45B6-B7E3-60BB51C8843B @default.
• Q38610220 P2093 Q38610220-4F8EA824-29C7-4425-AFB0-2EB54B2459B9 @default.
• Q38610220 P2093 Q38610220-6C37AC04-2998-4447-BC1E-BE3092AFAC96 @default.
• Q38610220 P2093 Q38610220-72A0567E-1AE7-41F8-84B7-3922D774FEBC @default.
• Q38610220 P2093 Q38610220-7A32495A-F14C-46C8-8E1D-22F289C542A8 @default.
• Q38610220 P2093 Q38610220-7DEB310A-6CDB-47EA-B26C-7510EE8DFC10 @default.
• Q38610220 P2093 Q38610220-A213543E-D964-4869-AA96-B40C2B856E9D @default.
• Q38610220 P2093 Q38610220-CC1208F5-1EDF-4DD2-AA38-DAAB8B689CB2 @default.
• Q38610220 P2093 Q38610220-CE204DE3-90B0-47B5-A9F2-92EC327E52D1 @default.
• Q38610220 P304 Q38610220-C5A21C02-1361-4115-8E1E-CE3DD0213FCF @default.
• Q38610220 P31 Q38610220-8B3FFF9B-AD86-4E0D-BF01-F82DCA9291C2 @default.
• Q38610220 P356 Q38610220-741C3BBC-19A2-4A45-8C48-51F94E63441C @default.
• Q38610220 P407 Q38610220-29838858-0D0D-4900-A374-33B17A88D2A3 @default.
• Q38610220 P50 Q38610220-27DEEDE7-D7ED-43E6-BE7F-8172BA47D119 @default.
• Q38610220 P577 Q38610220-82219965-0499-4FA7-B412-CEFDCCB778D3 @default.
• Q38610220 P698 Q38610220-71B0CB66-BF36-438C-AF62-50A6CE7E5438 @default.
• Q38610220 P921 Q38610220-42F19353-8B05-4A9D-ABBC-E969F5C5F29F @default.
• Q38610220 P356 JCO.2017.73.3675 @default.
• Q38610220 P698 28837405 @default.
• Q38610220 P1433 Q400292 @default.
• Q38610220 P1476 "Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study" @default.
• Q38610220 P2093 "Aaron R Hansen" @default.
• Q38610220 P2093 "Alain Algazi" @default.
• Q38610220 P2093 "Caroline Even" @default.
• Q38610220 P2093 "Chiun Hsu" @default.
• Q38610220 P2093 "Emilie M J van Brummelen" @default.
• Q38610220 P2093 "Janice M Mehnert" @default.

• next